Concepedia

John Yates

JY

Statistics

Publications

11

Citations

1.9K

H-Index

11

Active since

1996

Affiliations

Molecular Discovery (United Kingdom)(Current)

GlaxoSmithKline (United Kingdom)

New Frontier

GlaxoSmithKline (United States)

John Yates is an author at Molecular Discovery (United Kingdom) specializing in life sciences, pharmacology, and cholesterol biosynthesis.

Publications per year

1996–2020

11

Publications

11

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross et al. · Chemistry & Biology · 2000 · 895 citations · Full text

, , +11

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

Yu‐Tzu Tai, Patrick A. Mayes, Chirag Acharya et al. · Blood · 2014 · 480 citations

, , +12

The role of ATP citrate-lyase in the metabolic regulation of plasma lipids

John Yates, Theo A. Berkhout, Brian Jackson et al. · Biochemical Journal · 1998 · 139 citations · Full text

, , +14

Synthetic LXR agonists increase LDL in CETP species

Pieter H.E. Groot, John Yates, Claire J. Stocker et al. · Journal of Lipid Research · 2005 · 119 citations · Full text

, , +16

Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter

Jonathan R.S. Arch, John C. Clapham, Matthew P. Coghlan et al. · Metabolism · 2004 · 108 citations

, , +16

1–5 of 11